Has anyone else spotted this yet? "The presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on 30 May 2015 is expected to reveal “important new information…that facilitates a greater understanding of the implications and impact of the SIRFLOX study for SIR-Spheres Y-90 resin microspheres in first line mCRC, and how this may apply to clinical practice”."
In other words there might be some more good news to come in a couple of weeks, in addition to this abstract.
SRX Price at posting:
$26.46 Sentiment: Hold Disclosure: Held
